Clinical Trial Update: Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial evaluated the safety and potential efficacy of fingolimod for Rett syndrome in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• GILENYA (FINGOLIMOD HCL)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Rett's Syndrome | Phase 1, Phase 2 | Status: COMPLETED